SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3559 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2282...assumptions??? You want a bet? medpagetoday.com DME is where Eylea can peneMiljenko Zuanic-2/2/2018
2281Well, you may have something day early from SNY conference,... but than again...Miljenko Zuanic-2/1/2018
2280Lots of assumptions being made 1 week before we get something more substantial fThe Ox-2/1/2018
2279Who care what Barclay's Geoff Meacham think or write in his report/note? DoMiljenko Zuanic12/1/2018
2278<I do agree the market is a bit sensitive on any threats to eylea> A bit?Miljenko Zuanic-2/1/2018
2277I don't understand what the roche ab could do to overcome the opthotech and Felix B-2/1/2018
2276Regeneron continues slide, down 6% Feb. 1, 2018 3:48 PM ET|About: Regeneron PhaThe Ox-2/1/2018
2275Roche didn't give any specific (today CC) on Ang-2/VEGF combo, so next interMiljenko Zuanic-2/1/2018
2274Many times I mentioned that REGN MC is very sensitive to Eylea sale performance Miljenko Zuanic-2/1/2018
2273Do not know, hard to think about common sense rationale. They have activity, moMiljenko Zuanic-1/30/2018
2272So again this is for an orphan condition where there are some treatments alreadyFelix B-1/30/2018
2271Evinocumab (REGN1500) for HoFH and HeFH: In small HoFH-P2, it did fire (38-45%Miljenko Zuanic-1/29/2018
2270<REGN already tried the Ang2/Vegf combo and it didnt work, not expecting muchMiljenko Zuanic-1/27/2018
2269REGN already tried the Ang2/Vegf combo and it didnt work, not expecting much froFelix B-1/27/2018
2268Friday events: 1)Dupi under attack from upadacitinib 2) Eylea under attack from Miljenko Zuanic-1/26/2018
2267REGN: Yan, where is now your's "Advance Science" at Regeneron: roMiljenko Zuanic-1/26/2018
2266AZN has yet to report results from their combo KESTREL (H&N) and ARCTIC (NSCMiljenko Zuanic-1/25/2018
2265I thought AZN struck out with their PD1L/CTLA4 combo? How have the other PD1(L)Felix B-1/25/2018
2264Note that the 2810+Yervoy arm employs abbreviated chemo, presumably to avoid undDewDiligence_on_SI-1/25/2018
2263They are incorporating anti-CTLA4 with 2810 as well, for L1 NSCLC, good for BMY.Miljenko Zuanic-1/25/2018
2262Exactly and Repatha is already approved for HoFH? They must have some reasoningFelix B-1/24/2018
2261I am unclear too. Prevalence of HoHF in US is ~900 subjects, no room for many plMiljenko Zuanic-1/24/2018
2260That's why I am unclear why they are moving forward with 1500 unless they thFelix B-1/24/2018
2259Regardless of court ruling in Italy, this is small victory in EU for Lucentis, aMiljenko Zuanic-1/24/2018
2258I took latest MDCO dive to 25 as initial buy, so now am (even if for short perioMiljenko Zuanic-1/24/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News